Collaborations in brief.
- Published in:
- Chemistry & Industry, 2007, n. 2, p. 6
- Publication type:
- Article
Works matching DE "CAMBRIDGE Antibody Technology Group PLC"
Results: 21
1
2
Drug giant AstraZeneca swings CAT.
- Published in:
- Chemistry & Industry, 2006, n. 11, p. 7
- By:
- Publication type:
- Article
3
Blockbuster Humira a first for UK.
- Published in:
- Chemistry & Industry, 2006, n. 3, p. 5
- By:
- Publication type:
- Article
4
CAT and Abbott settle royalty payment dispute.
- Published in:
- Chemistry & Industry, 2005, n. 21, p. 5
- By:
- Publication type:
- Article
5
Business in brief.
- Published in:
- Chemistry & Industry, 2005, n. 4, p. 4
- Publication type:
- Article
6
CAT wins in Abbott dispute.
- Published in:
- Chemistry & Industry, 2005, n. 1, p. 6
- By:
- Publication type:
- Article
7
AstraZeneca buys into CAT.
- Published in:
- Chemistry & Industry, 2004, n. 23, p. 8
- By:
- Publication type:
- Article
8
License woes hit biotech.
- Published in:
- Chemistry & Industry, 2003, n. 23, p. 5
- Publication type:
- Article
9
Race hots up to buy OGS.
- Published in:
- Chemistry & Industry, 2003, n. 7, p. 6
- Publication type:
- Article
10
Potential biotech bidders eye OGS up for size.
- Published in:
- Chemistry & Industry, 2003, n. 5, p. 5
- Publication type:
- Article
11
Majors CAT and OG to merge.
- Published in:
- Chemistry & Industry, 2003, n. 3, p. 5
- Publication type:
- Article
12
Autonomy lost.
- Published in:
- Nature, 2007, v. 450, n. 7166, p. 17, doi. 10.1038/450017c
- Publication type:
- Article
13
Cambridge Antibody Technology plc: Interim results for the six months ended 31st March, 2004.
- Published in:
- Journal of Commercial Biotechnology, 2004, v. 11, n. 1, p. 97
- By:
- Publication type:
- Article
14
News In Brief.
- Published in:
- Nature Biotechnology, 2005, v. 23, n. 2, p. 161, doi. 10.1038/nbt0205-161
- By:
- Publication type:
- Article
15
UK bidding war amidst merger mania.
- Published in:
- Nature Biotechnology, 2003, v. 21, n. 4, p. 343, doi. 10.1038/nbt0403-343
- By:
- Publication type:
- Article
16
Cash crunch quells antibody litigation.
- Published in:
- Nature Biotechnology, 2003, v. 21, n. 2, p. 114, doi. 10.1038/nbt0203-114
- By:
- Publication type:
- Article
17
CAT's phage technology patent upheld.
- Published in:
- Nature Biotechnology, 2000, v. 18, n. 8, p. 809, doi. 10.1038/78333
- By:
- Publication type:
- Article
18
Transatlantic biotech deal.
- Published in:
- Nature Biotechnology, 2000, v. 18, n. 4, p. 366, doi. 10.1038/74346
- By:
- Publication type:
- Article
19
Patent case unblocks antibody businesses.
- Published in:
- Nature Biotechnology, 1999, v. 17, n. 12, p. 1154, doi. 10.1038/70691
- By:
- Publication type:
- Article
20
Belimumab: Anti-BLyS Human Monoclonal Antibody, Anti-BLyS Monoclonal Antibody, BmAb, Human Monoclonal Antibody to B-Lymphocyte Stimulator.
- Published in:
- Drugs in R&D, 2008, v. 9, n. 3, p. 197
- Publication type:
- Article
21
Lerdelimumab: 6B1, Anti-TGF-Beta-2 Monoclonal Antibody - Cambridge Antibody Technology, Anti-Transforming-Growth-Factor-Beta-2 Monoclonal Antibody - Cambridge Antibody Technology, CAT 152, Human Anti-TGF-Beta-2 Monoclonal Antibody - Cambridge Antibody Technology, TGF-Beta-2 Monoclonal Antibody - Cambridge Antibody Technology.
- Published in:
- Drugs in R&D, 2002, v. 3, n. 2, p. 106, doi. 10.2165/00126839-200203020-00006
- Publication type:
- Article